Pfizer

British lawmakers anxiously watching Pfizer-AstraZeneca talks

British lawmakers are concerned about the future of AstraZeneca and thousands of its employees, as U. S.-based pharmaceuticals giant Pfizer is preparing a £60 billion (nearly $100bn) takeover bid for the British firm.

Companies: 
General: 
People: 

AstraZeneca’s potential takeover by Pfizer may lead to thousands of job cuts

The potential takeover of British pharmaceuticals firm AstraZeneca by American drugs giant Pfizer has raised concerns about the future of British firm's employees.

Companies: 
General: 
People: 

Pfizer interested in AstraZeneca: report

American pharmaceuticals giant Pfizer Inc is reportedly mulling a plan to place a bid for struggling British drugs-maker AstraZeneca.

General: 
Companies: 

Spin-offs might possible show a ray of hope for Pfizer site

With the US maker Pfizer announcing the shutdown of its research and development site at Sandwich in Kent, the decision came as a blow this week as around 2,400 jobs are at risk.

The site, which has had remarkable success stories, was Pfizer's congregation for more than half a century. The site saw hits like the development of Viagra, the company's successful impotence drug, the Norvasc heart drug, and Celsentri, for HIV/Aids treatment.

General: 
Companies: 

3 in 10 Asians Prone to Overactive Bladder

On the basis of a research conducted by Pfizer, 59% of people suffered from the symptoms of overactive bladder (OAB).

The study found that three in 10 Asians are prone to overactive bladder (OAB), a medical condition that affects millions of people worldwide. OAB is caused due to loss of bladder control. People suffering from OAB often feel an urgent need to urinate almost eight times a day and sometimes it even results in uncontrollable leakage of urine due to urgency.

OAB negatively affects the emotional, physical and mental well-being. It also causes sexual problems.

Companies: 

Pages

Subscribe to RSS - Pfizer